A Look at the Thalidomide Tragedy
Below is a MRR and PLR article in category Health Fitness -> subcategory Other.
A Look at the Thalidomide Tragedy
Summary
During pregnancy, doctors advise caution with medications to protect the unborn child. Some drugs can lead to birth defects or even fetal death. The thalidomide tragedy is a stark example of this.Article
Today, we are aware that certain medications can adversely affect pregnant women and their unborn children. Unfortunately, this understanding came at a great cost, rooted in one of the most devastating medical errors in history.In the late 1950s and early 1960s, the German pharmaceutical company Chemie Grünenthal introduced a drug called thalidomide, originally discovered accidentally while trying to produce antibiotics. After some animal testing with high doses, the company mistakenly believed the drug was harmless with no side effects.
In 1955, Chemie Grünenthal began distributing free samples of thalidomide without extensive research or clinical trials. It was initially used by epilepsy patients to prevent seizures, who reported enhanced sleep and calming effects. Despite some side effects, these were largely ignored. By October 1, 1957, West German doctors began prescribing thalidomide under the brand name Contergan to pregnant women for morning sickness symptoms like nausea, vomiting, and insomnia. Its use quickly spread globally, sold under names like Distaval, Asmaval, and Valgraine, marketed also as a powerful sedative.
Pregnant women reported various side effects from the drug, including sleepiness, constipation, skin rashes, severe headaches, and more. Within a year, alarming birth defects emerged among babies of mothers who had taken thalidomide. These included phocomelia, characterized by severely malformed limbs, and other issues like missing or fused digits, deafness, blindness, disfigurement, cleft palate, and malformations of vital organs and systems. Shockingly, even a single thalidomide tablet taken during a critical point in the first trimester could cause these defects, as the drug is a teratogen that crosses the placenta, causing congenital deformities.
Initially, Chemie Grünenthal denied the rising cases of thalidomide-related deformities and fatalities in newborns. However, the media and scientific community began to highlight the devastating side effects. In the US, the FDA, led by Frances Kelsey, repeatedly denied approval for thalidomide due to insufficient data on its teratogenic effects. Her insistence on further studies on its effects during pregnancy and its chemistry and pharmacology prevented the drug’s approval under the name Kevadon by Richardson-Merrell.
By the time thalidomide was withdrawn worldwide, irreversible damage had been done. Approximately 10,000 infants were affected by deformities caused by the drug, and tragically, many did not survive into adulthood due to its severe impacts.
This tragedy underscores the critical importance of rigorous drug evaluation, especially for medications prescribed during pregnancy.
You can find the original non-AI version of this article here: A Look at the Thalidomide Tragedy.
You can browse and read all the articles for free. If you want to use them and get PLR and MRR rights, you need to buy the pack. Learn more about this pack of over 100 000 MRR and PLR articles.